6127 — Joinn Laboratories China Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapHigh Flyer

Annual income statement for Joinn Laboratories China Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	CAS	CAS	CAS	CAS	CAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,076	1,517	2,268	2,376	2,018
Cost of Revenue
Gross Profit	551	738	1,084	982	521
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	715	874	1,042	1,869	1,914
Operating Profit	361	643	1,226	507	104
Gain / Loss on Sale of Assets
Other Net Non Operating Costs
Net Income Before Taxes	361	642	1,240	507	104
Provision for Income Taxes
Net Income After Taxes	314	556	1,073	392	69.8
Minority Interest
Net Income Before Extraordinary Items
Net Income	315	557	1,074	397	74.1
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	315	557	1,074	397	74.1
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.507	0.766	1.43	0.828	0.209
Dividends per Share